key: cord-0862258-0slggs4l authors: Lambert, Francine; Jacomy, Hélène; Marceau, Gabriel; Talbot*, Pierre J title: Titration of Human Coronaviruses, HCoV-229E and HCoV-OC43, by an Indirect Immunoperoxidase Assay date: 2007-11-28 journal: SARS- and Other Coronaviruses DOI: 10.1007/978-1-59745-181-9_8 sha: afb8992c9091cffb4bd5e281734070ab2a54b011 doc_id: 862258 cord_uid: 0slggs4l Calculation of infectious viral titers represents a basic and essential experimental approach for virologists. Classical plaque assays cannot be used for viruses that do not cause significant cytopathic effects, which is the case for strains 229E and OC43 of human coronavirus (HCoV). An alternative indirect immunoperoxidase assay (IPA) is herein described for the detection and titration of these viruses. Susceptible cells are inoculated with serial logarithmic dilutions of samples in a 96-well plate. After viral growth, viral detection by IPA yields the infectious virus titer, expressed as “tissue culture infectious dose” (TCID(50)). This represents the dilution of a virus-containing sample at which half of a series of laboratory wells contain replicating virus. This technique is a reliable method for the titration of HCoV in biological samples (cells, tissues, or fluids). HCoV were first isolated in the mid-1960s from patients with upper respiratory tract disease (1-3). As described by McIntosh (4), the identification of coronaviruses in clinical samples was a very difficult task until the 1970s, as HCoV induced subtle or nonexistent cytopathic effects, and many cells types were not susceptible to the virus. Commonly Interestingly, cells from the central nervous system (CNS) were reported to be highly susceptible to HCoV replication. The SK-N-SH (ATCC: HTB-11) neuroblastoma and H4 (ATCC: HTB-148) neuroglioma cell lines were highly susceptible to infection, as well as astrocytoma cell lines U-87 MG (ATCC: HTB-14), U-373 MG, and GL-15 (5-8). Even though it was reported that HCoV-229E infectious titers could be determined by plaque assay on specific cell lines, such as MRC-5 or L-132 (6), this proved not to be a reliable assay and, as for HCoV-OC43, an alternative assay was required: an indirect immunoperoxidase assay (IPA) on coronavirus-susceptible cells to quantify infectious virus in biological samples. The immunoperoxidase assay is an enzymatic antigen detection technique that uses the enzyme horseradish peroxidase (HRP) to label antigen-antibody complexes. The principle of the IPA technique is that a specific antibody recognizes and binds to its specific antigen to yield an antibody-antigen complex. For detection of these complexes, the primary antibody is either directly labeled with HRP or remains unlabeled, with detection achieved by a labeled secondary antibody. If a secondary antibody is used, it must be generated against the immunoglobulins of the animal species in which the primary antibody was produced. The enzyme substrate, 3,3'-diaminobenzidine (DAB) is then converted by HRP to a precipitating brown end-product. 9 . Light microscope. 10. Incubator 37 • C. 1. To determine extracellular viral production, collect supernatants in sterile tubes from infected cells (to be tested) at appropriate times following infection. For estimation of intracellular viral titers, remove medium, wash cells in warm (37 • C) sterile PBS, then add the same volume or a known volume of medium and perform three cycles of freeze/thaw at -80 • C to lyse cells and release viral particles in the medium. 2. Collect medium samples in sterile tubes, centrifuge for 5 min at 1000 × g. 3. Collect supernatants in new sterile tubes and process to IPA detection, or immediately freeze at -80 • C and store until assayed. 1. Centrifuge nonadherent cells at 1000 × g for 5 min. 2. Collect supernatants in sterile tubes; they represent the extracellular portion of infectious virus. 3. Resuspend the cell pellet in the same volume (corresponding to the supernatant) or in a known volume of culture medium. 4. Perform three cycles of freeze/thaw at -80 • C to lyse cells and release the viral particles in the medium; they represent the intracellular portion of the infectious virus. 5. Centrifuge for 5 min at 1000 × g. 6. Collect supernatants in new sterile tubes and process to IPA detection, or immediately freeze at -80 • C and store until assayed. To verify the productivity of HCoV infection in biological samples, an immunoperoxidase assay is performed on coronavirus-susceptible cells. Suspensions of susceptible cells are prepared from confluent monolayers by trypsin treatment (trypsin [0.25% (w/v)] for the L132 cell line or trypsin/EDTA [0.05% (w/v)] for the HRT-18 cell line). Trypsin is then inactivated by the addition of culture medium supplemented by 10% (v/v) with fetal bovine serum (FBS). Susceptible cells are plated in a 96-well plate for tissue culture using a multichannel pipette. Dispense 100 l/well of cell suspension as follows. 1. When susceptible cells (L-132 for HCoV-229E or HRT-18 for HCoV-OC43) are at 70-80% confluence in the laminar flow hood, flick the medium of the 96-well plate. Remove residual medium by wrapping each plate in a sterile paper tissue and gently flicking it face down onto sterile paper. 2. Add 100 l of alpha-MEM supplemented with 1% (v/v) FBS to each well. 3 . Each sample should be tested in four adjacent columns in the same plate. Put 100 l/well of aliquots to be tested in the first row. 4. Inoculate with serial logarithmic dilutions of infected samples: Add 11 l/well of the same sample again in four wells in the second row of the 96-well plate. Mix with a multichannel pipette by pipetting up and down in the pipette tip three times and transfer 11 l/well in the third row and so forth to the last row of the plate (Fig. 1) . Change tips after every dilution and discard the remaining 11 l. 11. Stop the reaction with one wash with water as in step 5 and fill each well with 100 l deionized water. 12. Read plates with a light microscope to quantify all wells presenting stained cell (Fig. 2) Infectious virus titers (tissue culture infectious dose at 50%, TCID 50 ) are calculated by the Karber method (11): where D = -log 10 of the last dilution showing 100% (4 wells/4 wells) of virus positive wells; d = -log 10 of dilution factor. Example: -log 10 10 = -1.0; S = number of all wells presenting virus, including those showing 100% of viral positive wells; this last one representing the unit and other dilutions being a fraction of this unit. For an example see Fig. 3 (also see Note 4). = 2 + 1.5 = 3.5 log 10 (in 100 l as each well contain 100 l) The infectious titer of sample 1 is 4.5 log 10 /ml or 10 4.5 TCID 50 /ml. For organs or intracellular viral titers, keep in mind the dilution factor used. Normally tissue samples are diluted at 10% (w/v), so virus titers will be multiplied by 10. In example 1, the virus titer would be 10 5.5 TCID 50 /ml. 1. This protocol can be adapted for many other cell culture systems. HCoV-229E could be grown in normal human fetal lung fibroblast cells MRC-5 (ATCC: CCL-171) or Huh7 (12) and HCoV-OC43 in African green monkey kidney cells L-132 cell line (human lung epithelium; ATCC: CCL5) for HCoV-229E (see Note 1) HRT-18 cell line (human adenocarcinoma rectal (9)) for HCoV-OC43 (see Note 1) Alpha-MEM (alpha minimum essential medium; Invitrogen) Fetal bovine serum (FBS, Hyclone) Trypsin at 0.25% (w/v) for the L-132 cell line or trypsin/EDTA at 0.05% (w/v) for the HRT-18 cell line Multichannel pipette and sterile tips Incubator 33 • C with 5% (v/v) CO 2 Hydrogen peroxide 30% (Sigma) HCoV-229E: An ascites fluid or culture supernatant from mouse MAb 5-11H.6 (7, 10), directed against the surface glycoprotein (S) of HCoV-229E, or equivalent polyclonal antiserum b. HCoV-OC43: An ascites fluid or culture supernatant from mouse MAb 1-10C.3 (8) Secondary antibody: anti-mouse immunoglobulins conjugated to horseradish peroxidase (HRP; from KPL) at 1/500 dilution in PBS Multichannel pipette and tips Developing solution: 25-50 g/100 ml of freshly made DAB (3,3 -diaminobenzidine tetrahydrochloride) solution in PBS. Filter this solution on Whatman paper then add 0.01% hydrogen peroxide (33 l of H 2 O 2 30%). This solution is light sensitive and toxic Prepare sterile tubes for each organ and determine the weight of the empty tubes Quickly dissect the organs of interest in sterile conditions and keep them on ice. Rinse instruments in 70% (v/v) ethanol between each dissection Determine the weight of each biological sample Homogenize tissue samples to 10% (w/v) sterile PBS with a Polytron homogenizer in a laminar flow hood Centrifuge tubes at 4 • C, for 20 min at 1000 × g Collect supernatants in new sterile tubes and process to immunoperoxidase detection, or immediately freeze at -80 • C and store until assayed BS-C-1 (ATCC: CCL-26) or human rhabdomyosarcoma cell line RD-151 This protocol can be adapted using other sources of antibodies; e.g.: a. HCoV-229E: Murine monoclonal antibodies specific for the nucleocapsid protein (N) of HCoV-229E HCoV-OC43: Murine monoclonal antibody to HCoV-OC43 (Chemicon international) (14): clone 541-8f or An ascites fluid from mouse MAb O.4.3 (15), directed against the surface glycoprotein (S) of HCoV-OC43 An ascites fluid from mouse MAb 4E11.3 directed against the nucleocapsid (N) protein of the serologically related hemagglutinating encephalomyelitis virus of pigs HRP conjugate is sensitive to CO 2 and will lose its activity There are Excel spreadsheets to calculate TCID 50 /ml on the Internet at A new virus isolated from the human respiratory tract Growth in suckling mouse brain of "IBV-like" viruses from patients with upper respiratory tract disease Cultivation of a novel type of commoncold virus in organ cultures Coronavirus infection in acute lower respiratory tract disease of infants Regulation of viral persistence in human glioblastoma and rhabdomyosarcoma cells infected with coronavirus OC43 Neurotropism of human coronavirus 229E Persistent infection of human oligodendrocytic and neuroglial cell lines by human coronavirus 229E Acute and persistent infection of human neural cell lines by human coronavirus OC43 Cultural and antigenic properties of newly established cell strains derived from adenocarcinomas of the human colon and rectum Infection of primary cultures of human neural cells by human coronavirus 229E and OC43 Beitrag zar Kollktiven Behandlung Pharmakologischer Reiherersuche Comparative host gene transcription by microarray analysis early after infection of the Huh7 cell line by severe acute respiratory syndrome coronavirus and human coronavirus 229E Antigenic cross-reactivity between severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43 Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients Murine encephalitis caused by HCoV-OC43, a human coronavirus with broad species specificity, is partly immune-mediated This work was supported mainly by grant MT-9203 from the Canadian Institutes of Health Research (Institute of Infection and Immunity).